Osteoarthritis of Knee
Conditions
Brief summary
The purpose of this study is to compare objective and subjective measures of knee stability following total knee arthroplasty with a medial pivot design vs. a posterior stabilized design.
Detailed description
Several different prostheses are available for use in total knee arthroplasty (TKA). These designs aim to replicate the normal kinematics of the knee joint while maintaining stability throughout a full range of motion. The posterior cruciate ligament (PCL) contributes to these functions in the native knee, and if preserved it can function similarly in the prosthetic knee. Prostheses in which the PCL is sacrificed, and its function not replaced by other means, have poorer outcomes. However, various problems with preserving the PCL, including PCL deterioration in arthritic knees and difficulties with proper tensioning, have led to the development of alternative ways to emulate normal femoral rollback and sagittal plane stability. These posterior-substituted (PS) designs substitute for the PCL with either a cam and post mechanism or a symmetrical ultra-congruent tibial insert. The cruciate-retaining (CR) and PS designs, together with advances in surgical techniques and component materials, have achieved excellent implant survivorship with rates of \> 90% at 20 years. Reports of functional outcomes, however, have been variable. One potential area for improvement in TKA is optimization of implant design to better approximate native knee kinematics. In the normal knee, the medial condyle remains stable in the sagittal plane, functioning like a ball-and-socket, whereas the lateral condyle translates anterior to posterior during flexion. The designs of the CR and PS knees do not allow for this medial-centered rotation. Analysis has revealed paradoxical anterior sliding of the femur during flexion, abnormal axial rotation, and condylar lift-off. Edge loading and increased sagittal plane motion may predispose to accelerated polyethylene wear. The posterior stabilized design uses a cam-and-post mechanism in which one piece of the prosthesis has a plastic post that fits into a slot in the other piece of the prosthesis. A newer design that attempts to address these issues is the medial pivot knee (MP). This design is characterized by an asymmetrical tibial insert in which the medial compartment is ultra-congruent, providing antero-posterior stability and the lateral compartment allows for rollback around a medial axis of rotation i.e uses a ball-and-socket mechanism. This design more accurately recreates normal knee kinematics, reduces anteroposterior instability, and avoids condylar lift-off. Early studies indicate improved polyethylene wear characteristics. Midterm studies report excellent implant survivorship and clinical outcomes. Several randomized trials have compared the MP knee favorably with other designs. Patients with bilateral TKAs with a different prosthesis on each side preferred their medial pivot knee to a PS, CR, or mobile-bearing (MB) design. A trial comparing the MP and PS designs found greater range of motion (ROM) and better patient-reported outcomes in the MP group at 2 years. There also exists literature reporting poorer outcomes with the MP design. A trial involving 96 patients who had received both an MP knee and an MB knee on contralateral sides found lower ROM, higher complication rates, and worse patient reported outcomes in the MP knee. Given the lack of consensus in the literature, further investigation is warranted to determine the impact of the MP design on outcomes following TKA.
Interventions
DEVICEMedacta GMK posterior stabilized prosthesis
DEVICEMedacta GMK Sphere prosthesis
Sponsors
Northwestern University
Study design
Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
SINGLE (Subject)
Eligibility
Sex/Gender
ALL
Age
18 Years to 85 Years
Healthy volunteers
No
Inclusion criteria
* Age 18-85, regardless of gender, ethnicity, or pathology * Must require a total knee arthroplasty * All subjects must have given signed, informed consent prior to registration in study.
Exclusion criteria
* Minors * Any patients that are unable to consent * Patients with active infection or osseous tumor of the operative extremity * Patients undergoing revision surgery
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Score for the Knee Society Score (KSS) Function Component at 1 Year Post-operatively | 12 months post-operatively | Physician completed Knee Society Score questionnaire used to measure a patient's functional ability before and after total knee arthroplasty (TKA); score range is reported between 0-100 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 100) |
| Total Score Calculated Using the Forgotten Joint Score in Order to Assess the Subject's Ability to Forget the Artificial Joint in Everyday Life | 12 months post-operatively | Patient completed questionnaire used to assess the patients' ability to forget about a joint as a result of successful treatment. Every question is scored 1 (never) to 5 (mostly) according to the selected response categories. Thus, the raw score ranges from 12 to 60 where a high score indicates an improved outcome. The raw score is linearly transformed to a 0-100 scale and then reversed to obtain the final score with higher scores indicating improved physical function/reduced impact of symptoms on activity: Final score = 100 - ((sum(item01 to item12) - 12)/48\*100) |
| International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. | The International Knee Documentation Committe (IKDC) Questionnaire is a subjective scale that provides patients with an overall function score based on a summative score for 3 sub categories (knee function, sports activities, pain/symptoms). A score between 0-100 is obtained as the sum of scores for each individual question, with increasing composite scores correlating positively with patient functional status/quality of life. |
| Score for the Knee Society Score (KSS) Knee Component at 1 Year Post-operatively | 12 months post-operatively | Physician completed Knee Society Score questionnaire used to measure a patient's functional ability before and after total knee arthroplasty (TKA); score range is reported between 0-100 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 100) |
| Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | Pre-operatively on day of surgery, 6 weeks, 3 months, 6 months, 12 months and 24 months post-operatively | Patient completed Oxford Knee Score questionnaire used to assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA); score range is reported between 0-48 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 48) |
| Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. | Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Mental Composite Score (MCS) range from 5.2 to 76.3 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved mental wellness/function as reported by patients. |
| Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. | Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Physical Composite Score (MCS) range from 6.3 to 71.8 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved physical wellness/function as reported by patients. |
| PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. | Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Physical Function domain higher scores indicated improved physical function as reported by the patient |
| PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. | Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Interference domain an increased value indicates greater severity/frequency of pain reported by the patient. |
| PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively. | Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Behavior domain an increased value indicates greater severity/frequency of pain reported by the patient |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Assessing Knee Stability Using the KT-1000 Arthrometer (at 30 Degrees) | 1 year post-operatively | Used for grading the stability of the knee in various degrees of flexion according to section 4 of the International Knee Documentation Committee's Knee Ligament Standard Evaluation Form where normal (-1 to 2 mm); nearly normal (3 to 5 mm); abnormal (6 to 10 mm); severely abnormal (\>10 mm) |
| Get-up-and-Go Test | Between 6 months and 1 year post-operatively | Used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three metres, turn around, walk back to the chair, and sit down. |
| Assessing Knee Stability Using the KT-1000 Arthrometer (at 90 Degrees) | 1 year post-operatively | Used for grading the stability of the knee in various degrees of flexion according to section 4 of the International Knee Documentation Committee's Knee Ligament Standard Evaluation Form where normal (-1 to 2 mm); nearly normal (3 to 5 mm); abnormal (6 to 10 mm); severely abnormal (\>10 mm) |
Countries
United States
Participant flow
Participants by arm
| Arm | Count |
|---|---|
| Medacta Sphere Ball-and-socket
Medacta GMK Sphere prosthesis | 25 |
| Medacta PS Cam-and-post
Medacta GMK posterior stabilized prosthesis | 25 |
| Total | 50 |
Baseline characteristics
| Characteristic | Medacta Sphere | Medacta PS | Total |
|---|---|---|---|
| Age, Categorical <=18 years | 0 Participants | 0 Participants | 0 Participants |
| Age, Categorical >=65 years | 14 Participants | 10 Participants | 24 Participants |
| Age, Categorical Between 18 and 65 years | 11 Participants | 15 Participants | 26 Participants |
| Age, Continuous | 67 years STANDARD_DEVIATION 8 | 64 years STANDARD_DEVIATION 7 | 66 years STANDARD_DEVIATION 7.8 |
| Body Mass Index (BMI) | 32.8 kg/m^2 STANDARD_DEVIATION 5.82 | 34.2 kg/m^2 STANDARD_DEVIATION 5.81 | 33.5 kg/m^2 STANDARD_DEVIATION 5.81 |
| Coronary Artery Disease | 4 Participants | 2 Participants | 6 Participants |
| Diabetes Mellitus | 3 Participants | 6 Participants | 9 Participants |
| Ethnicity (NIH/OMB) Hispanic or Latino | 0 Participants | 0 Participants | 0 Participants |
| Ethnicity (NIH/OMB) Not Hispanic or Latino | 0 Participants | 0 Participants | 0 Participants |
| Ethnicity (NIH/OMB) Unknown or Not Reported | 25 Participants | 25 Participants | 50 Participants |
| History of VTE | 4 Participants | 1 Participants | 5 Participants |
| Hypertension | 20 Participants | 18 Participants | 38 Participants |
| Pre-Operative Ambulatory Status Cane | 10 Participants | 6 Participants | 16 Participants |
| Pre-Operative Ambulatory Status Unassisted | 11 Participants | 16 Participants | 27 Participants |
| Pre-Operative Ambulatory Status Walker | 4 Participants | 3 Participants | 7 Participants |
| Pre-operative Narcotic Use | 4 Participants | 4 Participants | 8 Participants |
| Race (NIH/OMB) American Indian or Alaska Native | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Asian | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Black or African American | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) More than one race | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Native Hawaiian or Other Pacific Islander | 0 Participants | 0 Participants | 0 Participants |
| Race (NIH/OMB) Unknown or Not Reported | 13 Participants | 15 Participants | 28 Participants |
| Race (NIH/OMB) White | 12 Participants | 10 Participants | 22 Participants |
| Region of Enrollment United States | 25 participants | 25 participants | 50 participants |
| Sex: Female, Male Female | 18 Participants | 15 Participants | 33 Participants |
| Sex: Female, Male Male | 7 Participants | 10 Participants | 17 Participants |
| Tobacco Use | 3 Participants | 5 Participants | 8 Participants |
Adverse events
| Event type | EG000 affected / at risk | EG001 affected / at risk |
|---|---|---|
| deaths Total, all-cause mortality | 0 / 0 | 0 / 0 |
| other Total, other adverse events | 0 / 0 | 0 / 0 |
| serious Total, serious adverse events | 0 / 0 | 0 / 0 |
Outcome results
Primary
International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op
The International Knee Documentation Committe (IKDC) Questionnaire is a subjective scale that provides patients with an overall function score based on a summative score for 3 sub categories (knee function, sports activities, pain/symptoms). A score between 0-100 is obtained as the sum of scores for each individual question, with increasing composite scores correlating positively with patient functional status/quality of life.
Time frame: Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Medacta Sphere | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | Baseline IKDC Composite | 35.82 score on a scale | Standard Deviation 8.72 |
| Medacta Sphere | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | 6 mo. IKDC Composite | 48.72 score on a scale | Standard Deviation 12.08 |
| Medacta Sphere | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | 1 yr. IKDC Composite | 57.97 score on a scale | Standard Deviation 13.79 |
| Medacta Sphere | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | 6 wk. IKDC Composite | 42.38 score on a scale | Standard Deviation 11.19 |
| Medacta Sphere | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | 2 yr. IKDC Composite | 51.26 score on a scale | Standard Deviation 8.67 |
| Medacta Sphere | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | 3 mo. IKDC Composite | 50.41 score on a scale | Standard Deviation 11.44 |
| Medacta PS | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | 2 yr. IKDC Composite | 49.3 score on a scale | Standard Deviation 10.56 |
| Medacta PS | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | 6 mo. IKDC Composite | 48.52 score on a scale | Standard Deviation 11.73 |
| Medacta PS | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | Baseline IKDC Composite | 35.97 score on a scale | Standard Deviation 6.97 |
| Medacta PS | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | 3 mo. IKDC Composite | 44.5 score on a scale | Standard Deviation 10.4 |
| Medacta PS | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | 1 yr. IKDC Composite | 52.66 score on a scale | Standard Deviation 13.23 |
| Medacta PS | International Knee Documentation Committee (IKDC) Questionnaire Assessed Through 2 Years Post-op | 6 wk. IKDC Composite | 43.91 score on a scale | Standard Deviation 7.68 |
Primary
Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative
Patient completed Oxford Knee Score questionnaire used to assess the patient's perspective of outcome following Total Knee Arthroplasty (TKA); score range is reported between 0-48 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 48)
Time frame: Pre-operatively on day of surgery, 6 weeks, 3 months, 6 months, 12 months and 24 months post-operatively
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Medacta Sphere | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | 6 mo. Post Op Oxford Knee Score | 33.67 score on a scale | Standard Deviation 8.9 |
| Medacta Sphere | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | Baseline Oxford Knee Score | 16.31 score on a scale | Standard Deviation 7.66 |
| Medacta Sphere | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | 1 yr. Post Op Oxford Knee Score | 39.16 score on a scale | Standard Deviation 9.97 |
| Medacta Sphere | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | 3 mo. Post Op Oxford Knee Score | 32.0 score on a scale | Standard Deviation 11.35 |
| Medacta Sphere | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | 2 yr. Post Op Oxford Knee Score | 40.41 score on a scale | Standard Deviation 8.56 |
| Medacta Sphere | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | 6 wk. Post Op Oxford Knee Score | 29.96 score on a scale | Standard Deviation 9.64 |
| Medacta PS | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | 2 yr. Post Op Oxford Knee Score | 38.28 score on a scale | Standard Deviation 11.8 |
| Medacta PS | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | 6 wk. Post Op Oxford Knee Score | 28.52 score on a scale | Standard Deviation 8.77 |
| Medacta PS | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | 3 mo. Post Op Oxford Knee Score | 32.7 score on a scale | Standard Deviation 9.47 |
| Medacta PS | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | 6 mo. Post Op Oxford Knee Score | 36.41 score on a scale | Standard Deviation 10.58 |
| Medacta PS | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | 1 yr. Post Op Oxford Knee Score | 35.81 score on a scale | Standard Deviation 11.33 |
| Medacta PS | Oxford Knee Score (OKS) Pre-operative Through 2 Years Post-operative | Baseline Oxford Knee Score | 19.88 score on a scale | Standard Deviation 9.39 |
Primary
PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative
Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Behavior domain an increased value indicates greater severity/frequency of pain reported by the patient
Time frame: Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | Baseline PROMIS Pain Behavior | 60.98 score on a scale | Standard Deviation 3.22 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | 3 mo. PROMIS Pain Behavior | 54.14 score on a scale | Standard Deviation 7.78 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | 2 yr. PROMIS Pain Behavior | 42.76 score on a scale | Standard Deviation 9.09 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | 6 wk. PROMIS Pain Behavior | 56.79 score on a scale | Standard Deviation 7.27 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | 1 yr. PROMIS Pain Behavior | 45.92 score on a scale | Standard Deviation 11.31 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | 6 mo. PROMIS Pain Behavior | 53.2 score on a scale | Standard Deviation 8.72 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | 2 yr. PROMIS Pain Behavior | 46.29 score on a scale | Standard Deviation 10.36 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | 1 yr. PROMIS Pain Behavior | 47.95 score on a scale | Standard Deviation 12.43 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | Baseline PROMIS Pain Behavior | 60.92 score on a scale | Standard Deviation 4.88 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | 6 wk. PROMIS Pain Behavior | 58.49 score on a scale | Standard Deviation 3.6 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | 3 mo. PROMIS Pain Behavior | 53.6 score on a scale | Standard Deviation 9.41 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Behavior Through 2 Years Post-operative | 6 mo. PROMIS Pain Behavior | 51.25 score on a scale | Standard Deviation 9.27 |
Primary
PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative
Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Pain Interference domain an increased value indicates greater severity/frequency of pain reported by the patient.
Time frame: Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | 6 wk. PROMIS Pain Interference | 58.23 score on a scale | Standard Deviation 8.59 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | Baseline PROMIS Pain Interference | 66.03 score on a scale | Standard Deviation 4.73 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | 3 mo. PROMIS Pain Interference | 55.9 score on a scale | Standard Deviation 11.48 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | 6 mo. PROMIS Pain Interference | 52.83 score on a scale | Standard Deviation 9.31 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | 1 yr. PROMIS Pain Interference | 46.65 score on a scale | Standard Deviation 11.22 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | 2 yr. PROMIS Pain Interference | 44.7 score on a scale | Standard Deviation 8.63 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | 1 yr. PROMIS Pain Interference | 49.98 score on a scale | Standard Deviation 11.22 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | 3 mo. PROMIS Pain Interference | 55.53 score on a scale | Standard Deviation 9.9 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | 6 mo. PROMIS Pain Interference | 53.27 score on a scale | Standard Deviation 12.35 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | Baseline PROMIS Pain Interference | 65.88 score on a scale | Standard Deviation 7.39 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | 6 wk. PROMIS Pain Interference | 58.2 score on a scale | Standard Deviation 7.62 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Pain Interference Through 2 Years Post-operative | 2 yr. PROMIS Pain Interference | 46.97 score on a scale | Standard Deviation 10.96 |
Primary
PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative
Patient-reported outcome (PRO) measures use answers that patients provide to questions to produce numeric values which indicate patients' state of wellbeing or suffering as well as their ability or lack of ability to function. Values are reported as T-scores with a reference population mean of 50 (SD=10); for the Physical Function domain higher scores indicated improved physical function as reported by the patient
Time frame: Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | Baseline PROMIS Physical Function | 32.92 score on a scale | Standard Deviation 4.44 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | 6 wk. PROMIS Physical Function | 38.38 score on a scale | Standard Deviation 6.95 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | 3 mo. PROMIS Physical Function | 42.12 score on a scale | Standard Deviation 8.14 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | 6 mo. PROMIS Physical Function | 43.81 score on a scale | Standard Deviation 7.26 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | 1 yr. PROMIS Physical Function | 48.06 score on a scale | Standard Deviation 9.22 |
| Medacta Sphere | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | 2 yr. PROMIS Physical Function | 49.17 score on a scale | Standard Deviation 7.84 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | 3 mo. PROMIS Physical Function | 41.32 score on a scale | Standard Deviation 6.76 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | Baseline PROMIS Physical Function | 31.24 score on a scale | Standard Deviation 5.27 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | 1 yr. PROMIS Physical Function | 48.9 score on a scale | Standard Deviation 10.25 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | 6 wk. PROMIS Physical Function | 39.96 score on a scale | Standard Deviation 6.45 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | 2 yr. PROMIS Physical Function | 46.5 score on a scale | Standard Deviation 8.97 |
| Medacta PS | PROMIS Computerized Adaptive Tests (CATs) for Physical Function Through 2 Years Post-operative | 6 mo. PROMIS Physical Function | 45.36 score on a scale | Standard Deviation 9.09 |
Primary
Score for the Knee Society Score (KSS) Function Component at 1 Year Post-operatively
Physician completed Knee Society Score questionnaire used to measure a patient's functional ability before and after total knee arthroplasty (TKA); score range is reported between 0-100 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 100)
Time frame: 12 months post-operatively
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Medacta Sphere | Score for the Knee Society Score (KSS) Function Component at 1 Year Post-operatively | 81.4 score on a scale | Standard Deviation 17.9 |
| Medacta PS | Score for the Knee Society Score (KSS) Function Component at 1 Year Post-operatively | 77.4 score on a scale | Standard Deviation 22.5 |
Primary
Score for the Knee Society Score (KSS) Knee Component at 1 Year Post-operatively
Physician completed Knee Society Score questionnaire used to measure a patient's functional ability before and after total knee arthroplasty (TKA); score range is reported between 0-100 with improvement in outcomes reflected as a higher numerical value (e.g. a 'complete' return to pre-disease functionality would be reported as a score of 100)
Time frame: 12 months post-operatively
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Medacta Sphere | Score for the Knee Society Score (KSS) Knee Component at 1 Year Post-operatively | 88.1 score on a scale | Standard Deviation 9.5 |
| Medacta PS | Score for the Knee Society Score (KSS) Knee Component at 1 Year Post-operatively | 86.0 score on a scale | Standard Deviation 12.6 |
Primary
Total Score Calculated Using the Forgotten Joint Score in Order to Assess the Subject's Ability to Forget the Artificial Joint in Everyday Life
Patient completed questionnaire used to assess the patients' ability to forget about a joint as a result of successful treatment. Every question is scored 1 (never) to 5 (mostly) according to the selected response categories. Thus, the raw score ranges from 12 to 60 where a high score indicates an improved outcome. The raw score is linearly transformed to a 0-100 scale and then reversed to obtain the final score with higher scores indicating improved physical function/reduced impact of symptoms on activity: Final score = 100 - ((sum(item01 to item12) - 12)/48\*100)
Time frame: 12 months post-operatively
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Medacta Sphere | Total Score Calculated Using the Forgotten Joint Score in Order to Assess the Subject's Ability to Forget the Artificial Joint in Everyday Life | 57.1 score on a scale | Standard Deviation 37.6 |
| Medacta PS | Total Score Calculated Using the Forgotten Joint Score in Order to Assess the Subject's Ability to Forget the Artificial Joint in Everyday Life | 54.6 score on a scale | Standard Deviation 41.6 |
Primary
Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative
Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Mental Composite Score (MCS) range from 5.2 to 76.3 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved mental wellness/function as reported by patients.
Time frame: Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Medacta Sphere | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | 6 mo. VR-12 MCS | 53.6 score on a scale | Standard Deviation 11.79 |
| Medacta Sphere | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | Baseline VR-12 MCS | 44.97 score on a scale | Standard Deviation 14.13 |
| Medacta Sphere | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | 6 wk. VR-12 MCS | 49.25 score on a scale | Standard Deviation 14.69 |
| Medacta Sphere | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | 3 mo. VR-12 MCS | 51.11 score on a scale | Standard Deviation 11.74 |
| Medacta Sphere | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | 2 yr. VR-12 MCS | 54.83 score on a scale | Standard Deviation 9.54 |
| Medacta Sphere | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | 1 yr. VR-12 MCS | 53.7 score on a scale | Standard Deviation 11.22 |
| Medacta PS | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | 2 yr. VR-12 MCS | 54.78 score on a scale | Standard Deviation 10.27 |
| Medacta PS | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | 3 mo. VR-12 MCS | 53.71 score on a scale | Standard Deviation 12.71 |
| Medacta PS | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | 6 mo. VR-12 MCS | 53.85 score on a scale | Standard Deviation 10.75 |
| Medacta PS | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | 1 yr. VR-12 MCS | 54.09 score on a scale | Standard Deviation 12.47 |
| Medacta PS | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | 6 wk. VR-12 MCS | 59 score on a scale | Standard Deviation 7.18 |
| Medacta PS | Veteran's RAND 12 (VR-12) Mental Composite Score (MCS) Through 2 Years Post Operative | Baseline VR-12 MCS | 54.33 score on a scale | Standard Deviation 12.35 |
Primary
Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative
Veteran's RAND 12 Item Health Survey used to assess health-related quality of life, to estimate disease burden, and to evaluate disease-specific benchmarks. Scores for the Physical Composite Score (MCS) range from 6.3 to 71.8 and are evaluated as a summative T-score with population mean of 50 (Standard Deviation = 10);higher scores indicate improved physical wellness/function as reported by patients.
Time frame: Pre-operatively, 6 weeks post-operatively, 3 months post-operatively, 6 months post-operatively, 12 months post-operatively, and 2 years post-operatively.
| Arm | Measure | Group | Value (MEAN) | Dispersion |
|---|---|---|---|---|
| Medacta Sphere | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | 2 yr. VR-12 PCS | 42.76 score on a scale | Standard Deviation 11.08 |
| Medacta Sphere | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | 6 wk. VR-12 PCS | 34.5 score on a scale | Standard Deviation 8.1 |
| Medacta Sphere | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | 1 yr. VR-12 PCS | 46.36 score on a scale | Standard Deviation 12.22 |
| Medacta Sphere | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | 3 mo. VR-12 PCS | 38.27 score on a scale | Standard Deviation 12.58 |
| Medacta Sphere | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | Baseline VR-12 PCS | 26.74 score on a scale | Standard Deviation 8.3 |
| Medacta Sphere | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | 6 mo. VR-12 PCS | 39.5 score on a scale | Standard Deviation 10.23 |
| Medacta PS | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | 6 mo. VR-12 PCS | 42.1 score on a scale | Standard Deviation 11.25 |
| Medacta PS | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | 1 yr. VR-12 PCS | 42.48 score on a scale | Standard Deviation 12.54 |
| Medacta PS | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | 2 yr. VR-12 PCS | 46.01 score on a scale | Standard Deviation 12.85 |
| Medacta PS | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | Baseline VR-12 PCS | 23.92 score on a scale | Standard Deviation 6.71 |
| Medacta PS | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | 6 wk. VR-12 PCS | 34.02 score on a scale | Standard Deviation 11.1 |
| Medacta PS | Veteran's RAND 12 (VR-12) Physical Composite Score (PCS) Through 2 Years Post Operative | 3 mo. VR-12 PCS | 35.9 score on a scale | Standard Deviation 10.28 |
Secondary
Assessing Knee Stability Using the KT-1000 Arthrometer (at 30 Degrees)
Used for grading the stability of the knee in various degrees of flexion according to section 4 of the International Knee Documentation Committee's Knee Ligament Standard Evaluation Form where normal (-1 to 2 mm); nearly normal (3 to 5 mm); abnormal (6 to 10 mm); severely abnormal (\>10 mm)
Time frame: 1 year post-operatively
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Medacta Sphere | Assessing Knee Stability Using the KT-1000 Arthrometer (at 30 Degrees) | 5.6 millimeters | Standard Deviation 1.9 |
| Medacta PS | Assessing Knee Stability Using the KT-1000 Arthrometer (at 30 Degrees) | 10.2 millimeters | Standard Deviation 2.7 |
Secondary
Assessing Knee Stability Using the KT-1000 Arthrometer (at 90 Degrees)
Used for grading the stability of the knee in various degrees of flexion according to section 4 of the International Knee Documentation Committee's Knee Ligament Standard Evaluation Form where normal (-1 to 2 mm); nearly normal (3 to 5 mm); abnormal (6 to 10 mm); severely abnormal (\>10 mm)
Time frame: 1 year post-operatively
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Medacta Sphere | Assessing Knee Stability Using the KT-1000 Arthrometer (at 90 Degrees) | 4.1 millimeters | Standard Deviation 2 |
| Medacta PS | Assessing Knee Stability Using the KT-1000 Arthrometer (at 90 Degrees) | 5.6 millimeters | Standard Deviation 1.9 |
Secondary
Get-up-and-Go Test
Used to assess a person's mobility and requires both static and dynamic balance. It uses the time that a person takes to rise from a chair, walk three metres, turn around, walk back to the chair, and sit down.
Time frame: Between 6 months and 1 year post-operatively
| Arm | Measure | Value (MEAN) | Dispersion |
|---|---|---|---|
| Medacta Sphere | Get-up-and-Go Test | 10.2 seconds | Standard Deviation 3.7 |
| Medacta PS | Get-up-and-Go Test | 10.5 seconds | Standard Deviation 5 |